Skip to main content

Patient Search

Testimonials Testimonials

Displaying 81 - 90 of 280

A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Patients with Metastatic Colorectal Cancer

Multiple Cancer Types

Colon, Rectal
I/II
Eng, Cathy
NCT04660812
VICCGIP2113

A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases.

Breast

Breast
II
Kennedy, Laura
NCT04647916
SWOGBRES2007


Phase I, Two-Part, Multi-Center, First-in-Human Study of DS-6000a in Subjects with Advanced Renal Cell Carcinoma and Ovarian Tumors

Multiple Cancer Types

Kidney (Renal Cell), Ovarian, Phase I
I
Rini, Brian
NCT04707248
VICCPHI2115

Acalabrutinib for Chronic Graft-Versus-Host Disease

Miscellaneous

Miscellaneous
II
Kitko, Carrie
NCT04198922
VICCCTT2122

Pilot Testing of the Body Image after Head and Neck Cancer Treatment (BIHNC) Program

Head/Neck

Head/Neck
N/A
Rhoten, Bethany
NCT04830488
VICCHN2123

A Phase 1 Study of SEA-TGT (SGN-TGT) in Subjects with Advanced Malignancies

Multiple Cancer Types

Gastric/Gastroesophageal, Head/Neck, Lung, Non Small Cell, Ovarian, Phase I
I
Crispens, Marta
NCT04254107
VICCPHI2125

A Phase 1, Dose-Escalation Study to Evaluate Safety and Tolerability of Belzutifan (MK-6482) in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Multiple Cancer Types

Kidney (Renal Cell), Phase I
I
Beckermann, Kathryn
NCT04846920
VICCUROP2127

A Phase 1/2 Study to Evaluate Safety and Efficacy of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination with Ruxolitinib, in Treatment Nave Patients with Myelofibrosis

Multiple Cancer Types

Hematologic, Phase I
I/II
Mohan, Sanjay
NCT04562389
VICCHEMP2130